Concepedia

Oliver Schofield

OS

2

Publications

123

Citations

2

H-Index

2016

Active since

Affiliations

Cancer Research UK(Current)

University College London

Oliver Schofield is an author at Cancer Research UK specializing in surgical oncology, health sciences, and cancer research.

Top concepts

Publications per year

2016–2021

2

Publications

2

4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial

Peter Hoskin, B. Popova, Oliver Schofield et al. · The Lancet Oncology · 2021 · 104 citations

, , +9

R2W: Subcutaneous Bortezomib, Cyclophosphamide and Rituximab (BCR) Versus Fludarabine, Cyclophosphamide and Rituximab (FCR) for Initial Therapy of WaldenstrőM's Macroglobulinemia: A Randomised Phase II Study

Rebecca Auer, Roger G. Owen, Shirley D’Sa et al. · Blood · 2016 · 19 citations

Rows per page

1–2 of 2